請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/54994
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 蘇璧伶(Bi-Ling Su) | |
dc.contributor.author | Ching-An Chen | en |
dc.contributor.author | 陳慶安 | zh_TW |
dc.date.accessioned | 2021-06-16T03:43:45Z | - |
dc.date.available | 2020-03-13 | |
dc.date.copyright | 2015-03-13 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2015-02-10 | |
dc.identifier.citation | 彭子庭。2011。被動免疫與抗病毒藥物於犬瘟熱治療之評估。國立台灣大學獸醫
研究所碩士論文。 Amude, A.M., Alfieri, A.A., Alfieri, A.F., 2007, Clinicopathological findings in dogs with distemper encephalomyelitis presented without characteristic signs of the disease. Res Vet Sci 82, 416-422. Appel, M.J.G., Robson, D.A., 1973, A microneutralization test for canine distemper virus. Am J Vet Res 34:1459-1463. Appel, M.J., Shek, W.R., Summers, B.A., 1982, Lymphocyte-mediated immune cytotoxicity in dogs infected with virulent canine distemper virus. Infect Immun 37, 592-600. Appel, M.J.G., Yates, R.A., Foley, G.L., Bernstein, J.J., Santinelli, S., Spelman, L.H., Miller, L.D., Arp, L.H., Anderson, M., Barr, M., et al., 1994, Canine distemper epizootic in lions, tigers, and leopards in North America. J Vet Diagn Investig 6, 277-288. Blixenkrone-Moller, M., Svansson, V., Have, P., 1993, Studies on manifestations of canine distemper virus infection in an urban population. Vet Microbiol 37, 163-173. Bolt, G., Jensen, T.D., Gottschalck, E., Arctander, P., Appel, M.J., Buckland, R., Blixenkrone-Moller, M., 1997, Genetic diversity of the attachment (H) protein gene of current field isolates of canine distemper virus. J Gen Virol 78 (Pt 2), 367-372. Carvalho, O.V., Botelho, C.V., Ferreira, C.G., Scherer, P.O., Soares-Martins, J.A., Almeida, M.R., Silva Junior, A., 2012, Immunopathogenic and Neurological Mechanisms of Canine Distemper Virus. Adv Virol 2012, 163860. Chen, C.C., Pei, K.J., Liao, M.H., Mortenson, J.A., 2008, Canine distemper virus in wild ferret-badgers of Taiwan. J Wildl Dis 44, 440-445. Dart, R.C., Seifert, S.A., Boyer, L.V., Clark, R.F., Hall, E., McKinney, P., McNally, J., Kitchens, C.S., Curry, S.C., Bogdan, G.M., Ward, S.B., Porter, R.S., 2001, A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med 161, 2030-2036. De Vries, P., Uytdehaag, F.G., Osterhaus, A.D., 1988, Canine distemper virus (CDV) Immune-stimulating complexes (Iscoms), but not measles virus iscoms, protect dogs against CDV infection. J Gen Virol 69, 2071-2083. Greene, C.E., Appel, M.J., 1998, Infectious Diseases of the Dogs and Cats II 9-22. Greene, C.E., Appel, M.J., 2012. Infectious Diseases of the Dogs and Cats IV 25-42. Grone, A., Engelhardt, P., Zurbriggen, A., 2003, Canine distemper virus infection: proliferation of canine footpad keratinocytes. Vet Pathol 40, 574-578. Haines, D.M., Martin, K.M., Chelack, B.J., Sargent, R.A., Outerbridge, C.A., Clark, E.G., 1999, Immunohistochemical detection of canine distemper virus in haired skin, nasal mucosa, and footpad epithelium: a method for antemortem diagnosis of infection. J Vet Diagn Invest 11, 396-399. Han, G.Z., Liu, X.P., Li S.S., 2008, Cross-species recombination in the haemagglutinin gene of canine distemper virus. Virus Res 136:198-201. Harder, T.C., Osterhaus, A.D., 1997, Canine distemper virus—a morbillivirus in search of a new host. Trends Microbiol 5, 120-124. Hirama, K., Goto, Y., Uema, M., Endo, Y., Miura, R., Kai, C., 2004, Phylogenetic analysis of the hemagglutinin (H) gene of canine distemper viruses isolated from wild masked palm civets (Paguma larvata). J Vet Med Sci 66, 1575- 1578. Hirayama, N., Senda, M., Nakashima, N., Takagi, M., Sugiyama, M., Yoshikawa, Y., Yamanouchi, K., 1991, Protective effects of monoclonal antibodies against lethal canine distemper virus infection in mice. J Gen Virol 72 , 2827-2830. Ho, C.K., Babiuk, L.A., 1979, Immune mechanisms against canine distemper. II. Role of antibody in antigen modulation and prevention of intercellular and extracellular spread of canine distemper virus. Immunology 38, 765-772. Ho, C.K., Babiuk, L.A., 1980, Immune mechanisms against canine distemper. III. Role of complement lysis in the immunity and persistent infection of canine distemper virus. Immunology 39, 231-237. Ikeda, Y., Nakamura, K., Miyazawa, T., Chen, M.C., Kuo, T.F., Lin, J.A., Mikami, T., Kai, C., Takahashi, E., 2001, Seroprevalence of canine distemper virus in cats. Clin Diagn Lab Immunol 8, 641-644. Jahrling, P.B., Geisbert, J.B., Swearengen, J.R., Larsen, T., Geisbert, T.W., 2007, Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates. J Infect Dis 196, S400-S403. Jozwik, A., Frymus, T., 2005, Comparison of the immunofluorescence assay with RT-PCR and nested PCR in the diagnosis of canine distemper. Vet Res Commun 29, 347-359. Keller, M.A., Stiehm, E.R., Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 2000, 13:602-614. Kim, Y.H., Cho, K.W., Youn, H.Y., Yoo, H.S., Han, H.R., 2001, Detection of canine distemper virus (CDV) through one step RT-PCR combined with nested PCR. J Vet Sci 2, 59-63. Krakowka, S., Mador, R.A. and Koestner. A., 1978., 1978, Canine distemper virus-associated encephalitis: modification by passive antibody administration. Acta Neuropathol 43, 235-241. Krakowka, S., Higgins, R.J., Metzler, A.E., 1980, Plasma phase viremia in canine distemper virus infection. Am J Vet Res 41, 144-146. Laidlaw, P.P., Dunkin, G.W., 1931, Studies in Dog Distemper VI Dog Distemper Antiserum. J Comp Path 41, p. 1. Lan, N.T., Yamaguchi, R., Inomata, I., 2006, Comparative analyses of canine distemper viral isolates from clinical cases of canine distemper in vaccinated dogs. Vet Microbiol 115, 32-42. Lauder, I.M., Martin, W.B., Gordon, E.B., Lawson, D.D., Campbell, R.S.F., Watrach, A.M., 1954, Vet. Rec. 66, 607–611. Lednicky, J.A., Dubach, J., Kinsel, M.J., Meehan, T.P., Bocchetta, M., Hungerford, L.L., Sarich, N.A., Witecki, K.E., Braid, M.D., Pedrak, C., Houde, C.M., 2004a, Genetically distant American Canine distemper virus lineages have recently caused epizootics with somewhat different characteristics in raccoons living round a large suburban zoo in the USA. Virol J 1, 2. Liang, C.T., Chueh, L.L., Lee, K. H., Huang, H.S., Uema, M., Watanabe, A., Miura, R., Kai, C., Liang, S. C., Yu, C.K., Liu, C.H., 2008, Phylogenetic Analysis and Isolation of Canine Distemper Viruses in Taiwan. Taiwan Vet J 34 (4), 198-210. Martella, V., Elia, G., Buonavoglia, C., 2008, Canine distemper virus. Vet Clin North Am Small Anim Pract 38, 787-797, vii-viii. Murphy, F.A., 1999, Veterinary Virology, In: Gibbs, E.P.J., Horzinek, M.C., Studdert, M.J. (Ed.), pp. 411-428. McCullough, B., Krakowka, S., Koestner, A., Shadduck, J., 1974a, Demyelinating activity of canine distemper virus isolates in gnotobiotic dogs. J Infect Dis 130, 343-350. McCullough, B., Krakowka, S., Koestner, A., 1974b, Experimental canine distemper virus-induced demyelination. Lab Invest 31, 216-222. Muhlebach, M.D., Mateo, M., Sinn, P.L., Prufer, S., Uhlig, K.M., Leonard, V.H.J., Navaratnarajah, C.K., Frenzke, M., Wong, X.X., Sawatsky, B., 2011, Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature , 10639. Nagao, Y., Nishio, Y., Shiomoda, H., Tamaru, S., Shimojima, M., Goto, M., Une, Y., Sato, A., Ikebe, Y., Maeda, K., 2012, An outbreak of canine distemper virus in tigers (Panthera tigris): possible transmission from wild animals to zoo animals. J Vet Med Sci 74, 699-705. Nouvellet, P., Donnelly, C.A., De Nardi, M., Rhodes, C.J., De Benedictis, P., Citterio,C., Obber, F., Lorenzetto, M., Dalla Pozza, M., Cauchemez, S., Cattoli, G., 2013, Rabies and Canine Distemper Virus Epidemics in the Red Fox Population of Northern Italy (2006-2010). PLoS One 8, e61588. Orlando, E.A., Imbschweiler, I., Gerhauser, I., Baumgartner, W., Wewetzer, K., 2008, In vitro characterization and preferential infection by canine distemper virus of glial precursors with Schwann cell characteristics from adult canine brain. Neuropathol Appl Neurobiol 34, 621-637. Pratakpiriya, W., Seki, F., Otsuki, N., Sakai, K., Fukuhara, H., Katamoto, H., Hirai, T., Maenaka, K., Techangamsuwan, S., Lan, N.T., Takeda, M., Yamaguchi, R., 2012, Nectin4 is an epithelial cell receptor for canine distemper virus and involved in the neurovirulence. J Virol 86, 10207–10210. Raw, M.E., Pearson, G.R., Brown, P.J., Baumgartner, W., 1992, Canine distemper infection associated with acute nervous signs in dogs. Vet Rec 130, 291-293. Rima, B.K., Baczko, K., Clarke, D.K., Curran, M.D., Martin, S.J., Billeter, M.A., ter Meulen, V., 1986, Characterization of clones for the sixth (L) gene and a transcriptional map for morbilliviruses. J Gen Virol 67 (Pt 9), 1971-1978. Rima, B.K., Duffy, N., Mitchell, W.J., Summers, B.A., Appel, M.J., 1991, Correlation between humoral immune responses and presence of virus in the CNS in dogs experimentally infected with canine distemper virus. Arch Virol 121, 1-8. Rudd, P.A., Cattaneo, R., von Messling, V., 2006, Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion. J Virol 80, 9361-9370. Schobesberger, M., Summerfield, A., Doherr, M.G., Zurbriggen, A., Griot, C., 2005, Canine distemper virus-induced depletion of uninfected lymphocytes is associated with apoptosis. Vet Immunol Immunopathol 104, 33-44. Schumaker, B.A., Miller, M.M., Grosdidier, P., Cavender, J.L., Montgomery, D.L., Cornish, T.E., Farr, R.M., Driscoll, M., Maness, L.J., Gray, T., Petersen, D., Brown, W.L., Logan, J., O'Toole, D., 2012, Canine distemper outbreak in pet store puppies linked to a high-volume dog breeder. J Vet Diagn Invest 24, 1094-1098. Schwartzberg, P.L., Mueller, K.L., Qi, H., and Cannons, J.L., 2009, SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat. Rev Immunol 9, 39–46. Seibel, H., Baumgartner, W., Muller, G., Wohlsein, P., Siebert, U., 2007, Retrospective analysis of two phocine distemper epidemics in the North and Baltic Seas in 1988 and 2002. Dtsch Tierarztl Wochenschr 114, 284-293. Seki, F., Ono, N., Yamaguchi, R., Yanagi, Y., 2003, Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells. J Virol 77, 9943–9950. Shin, Y.J., Cho, K.O., Cho, H.S., Kang, S.K., Kim, H.J., Kim, Y.H., Park, H.S., Park,N.Y., 2004, Comparison of one-step RT-PCR and a nested PCR for the Detection of canine distemper virus in clinical samples. Aust Vet J 82, 83-86. Stiehm, E.R., Keller, M.A., 2009, Passive immunization. In: Feigin, R.D, Cherry, J., Demmler-Harrison, G.J., Kaplan, S.L. (Eds.), Feigin & Cherry's textbook of pediatric infectious diseases. 6th ed. Sauders Elsevier, Philadelphia, pp. 3401-3446. Tipold, A., Vandevelde, M., Jaggy, A., 1992, Neurological manifestations of caninedistemper virus infection. J Small Anim Pract 33, 466-470. Vandevelde, M., Zurbriggen, A., 2005, Demyelination in canine distemper virus infection: a review. Acta Neuropathol 109, 56-68. von Messling, V., Zimmer, G., Herrler, G., Haas, L., Cattaneo, R., 2001, The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J Virol 75, 6418-6427. von Messling, V., Springfeld, C., Devaux, P., Cattaneo, R., 2003, A ferret model of canine distemper virus virulence and immunosuppression. J Virol 77, 12579- 12591. von Messling, V., Svitek, N., Cattaneo, R., 2006, Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus. J Virol 80, 6084-6092. Yi, L., Cheng, S., Xu, H., 2012, Development of a combined canine distemper virus specific RT-PCR protocol for the differentiation of infected and vaccinated animals (DIVA) and genetic characterization of the hemagglutinin gene of seven Chinese strains demonstrated in dogs. J Virol Methods 179, 281–287. Wohlsein, P., Muller, G., Haas, L., Siebert, U., Harder, T.C., Baumgartner, W., 2007, Antigenic characterization of phocine distemper virus causing mass mortality in 2002 and its relationship to other morbilliviruses. Arch Virol 152, 1559-1564. Wyss-Fluehmann, G., Zurbriggen, A., Vandevelde, M., Plattet, P., 2010, Canine distemper virus persistence in demyelinating encephalitis by swift intracellular cell-to-cell spread in astrocytes is controlled by the viral attachment protein. Acta Neuropathol 119, 617-630. Yoshikawa, Y., Ochikubo, F., Matsubara, Y., Tsuruoka, H., Ishii, M., Shirota, K., Nomura, Y., Sugiyama, M., Yamanouchi, K., 1989, Natural infection with canine distemper virus in a Japanese monkey (Macaca fuscata). Vet Microbiol 20, 193-205. Zhao, J.J., Yan, X.J., Chai, X.L., Martella, V., Luo, G.L., Zhang, H.L., Gao, H., Liu,Y.X., Bai, X., Zhang, L., Chen, T., Xu, L., Zhao, C.F., Wang, F.X., Shao, X.Q.,Wu, W., Cheng, S.P., 2010, Phylogenetic analysis of the haemagglutinin gene of canine distemper virus strains detected from breeding foxes, raccoon dogs and minks in China. Vet Microbiol 140, 34-42. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/54994 | - |
dc.description.abstract | 犬瘟熱為一盛行全世界的傳染病,由副黏液病毒科,麻疹病毒屬的犬瘟熱病毒傳播,在犬科及其他許多食肉動物都具有高度傳染性和死亡率。本實驗室與動物科技研究所合作製作豬源抗犬瘟熱病毒中和抗體IgG及抗體F(ab’)2,評估異源抗體對於自然感染犬瘟熱發病患犬的治療效果。此研究收集自然感染犬瘟熱,已出現呼吸道等症狀,但尚未出現神經症狀患犬共62隻。患犬分為兩組,第一組 (n=29)為給予抗體IgG或是抗體F(ab’)2合併對症治療組,第二組 (n=33)為僅接受對症治療組。第一組的存活率為69% (20/29)顯著高於第二組的33.3% (11/33) (p < 0.05)。第一組中,治療期間出現神經症狀患犬的存活率為41.7% (5/12),第二組治療期間出現神經症狀的患犬僅一隻存活,存活率為4.8%,兩組間具有統計上之差異 (p < 0.05)。研究中施打抗體的犬隻皆未出現嚴重副作用,只有在施打抗體IgG的患犬觀察到高體溫的現象,但在施打抗體F(ab’)2的患犬則無此現象。總結,本研究之結果顯示豬源抗犬瘟熱病毒抗體IgG及抗體F(ab’)2於犬瘟熱感染患犬有顯著的治療效果,且因其副作用輕微,未來除家犬之外亦可使用於其他會感染犬瘟熱而死亡的食肉動物,尤其是瀕臨絕種的動物。 | zh_TW |
dc.description.abstract | Canine distemper (CD) is a globally distributed infectious disease caused by a morbillivirus of the family Paramyxoviridae. The canine distemper virus (CDV) causes one of the most contagious and lethal diseases of canids and wild carnivores. Porcine anti-CDV antibodies IgG and F(ab’)2 were both pilot products derived from Animal Department of Agriculture Technology Research Institute, Miaoli, Taiwan. A total of 29 CDV-naturally infected dogs with respiratory but not developing neurological signs were treated with a combination of IgG or F(ab’)2 and supportive therapy (group 1). Group 2 comprised 33 dogs with similar clinical signs that received only supportive therapy. The survival rate of group 1 (69%, 20/29) was significantly higher than that of group 2 (33.3%, 11/33) (p < 0.05). In group 1, five dogs (41.7%, 5/12) that developed neurological signs during therapy survived, compared to only one dog (4.8%, 1/21) in group 2, a significant difference (p < 0.05). In addition, no obvious severe side effects were observed during therapy. Only hyperthermia was observed in dogs that received IgG but not those that received F(ab’)2. In conclusion, porcine anti-CDV antibodies exhibit promising therapeutic efficacy with minimal side effect in the treatment of CD dogs. Besides dog, this therapy can be considered for treating other endangered animal species with CDV infection. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T03:43:45Z (GMT). No. of bitstreams: 1 ntu-104-R01643008-1.pdf: 346036 bytes, checksum: 44f06ad2867fd42c08bd5c984e34d182 (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | 中文摘要...........................................................................................................................i
ABSTRACT.....................................................................................................................ii CONTENTS.....................................................................................................................iv LIST OF TABLES..........................................................................................................vii LIST OF FIGURE..........................................................................................................viii Chapter 1 Introduction................................................................................................1 1.1 History..............................................................................................................1 1.2 Etiology.............................................................................................................1 1.3 Epidemiology....................................................................................................4 1.4 Pathogenesis.....................................................................................................5 1.4.1 Systemic infection.................................................................................5 1.4.2 Central nervous system infection..........................................................7 1.5 Clinical features................................................................................................8 1.5.1 Systemic signs.......................................................................................8 1.5.2 Neurologic signs....................................................................................9 1.6 Diagnosis........................................................................................................10 1.6.1 Clinical laboratory findings...............................................................10 1.6.2 Cerebrospinal fluid analysis...............................................................11 1.6.3 Immunocytology and immunohistochemistry.....................................11 1.6.4 Nucleic acid detection........................................................................13 1.6.5 Viral isolation......................................................................................14 1.6.6 Serum antibody testing......................................................................14 1.7 Therapy...........................................................................................................14 Chapter 2 Material and methods..............................................................................17 2.1 Study design...................................................................................................17 2.2 Animals...........................................................................................................17 2.3 Laboratory examinations................................................................................18 2.4 Source of porcine anti-CDV antibody IgG and F(ab’)2...................18 2.5 Serum neutralization (SN) test.......................................................................19 2.6 Administration of porcine anti-CDV antibodies............................................19 2.7 Detection of virus pathogens via RT-nested PCR or nested PCR...................20 2.8 Statistical analysis...........................................................................................21 Chapter 3 Result.........................................................................................................22 3.1 Signalments....................................................................................................22 3.2 Survival rates..................................................................................................22 3.3 Laboratory findings and co-infections............................................................23 3.4 Serum neutralization antibody titer in group 1...............................................24 3.5 Detection rates of CDV RT-nested PCR in group 1.......................................25 Chapter 4 Discussion..................................................................................................27 Reference.........................................................................................................................30 Tables...............................................................................................................................41 Figure...............................................................................................................................50 Appendix 1......................................................................................................................51 Appendix 2......................................................................................................................52 LIST OF TABLES Table 1 Signalments of 29 dogs in group 1..................................................................41 Table 2 Signalments of 33 dogs in group 2..................................................................42 Table 3 The survival rates of 62 canine distemper dogs between group 1 and group 2.......................................................................................................................................43 Table 4 The survival rates of 29 canine distemper dogs between group 1a (IgG) and group 1b [F(ab’)2]...............................................................................44 Table 5 Hematological findings of 60 CD dogs at presenting......................................45 Table 6 Co-infections of 29 CD dogs in group 1..........................................................46 Table 7 SN titer varieties of 29 CD dogs in group 1....................................................47 Table 8 CDV RT-nPCR detection rates from different sampling sites between survival and non-survival dogs in group 1....................................................................48 Table 9 CDV RT-nPCR detection rates from different sampling sites upon presenting of neurologic signs in 12 dogs in group 1.......................................................49 LIST OF FIGURE Fig. 1 Survival rates between group 1 and group 2......................................................50 | |
dc.language.iso | zh-TW | |
dc.title | 豬源抗犬瘟熱病毒抗體 [IgG或F(ab’)2]於犬瘟熱患犬之臨床測試 | zh_TW |
dc.title | Clinical Trials of Porcine anti-CDV Antibodies [IgG or F(ab’)2] in Canine Distemper Infected Dogs | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 闕玲玲(Ling-Ling Chueh),陳啟銘(Chi-min Chen),梁鍾鼎(Chung-Tiang Liang) | |
dc.subject.keyword | 犬瘟熱,被動免疫治療,異源抗體,抗體IgG,抗體F(ab’)2, | zh_TW |
dc.subject.keyword | canine distemper,passive immunotherapy,xenogeneic antibody,IgG,F(ab’)2, | en |
dc.relation.page | 53 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2015-02-10 | |
dc.contributor.author-college | 獸醫專業學院 | zh_TW |
dc.contributor.author-dept | 臨床動物醫學研究所 | zh_TW |
顯示於系所單位: | 臨床動物醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf 目前未授權公開取用 | 337.93 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。